Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3466264
Title:
PROCÉDÉS D'ADMINISTRATION DE MÉDICAMENTS COMPRENANT LE DÉPLOIEMENT ET LE REPLIEMENT DE PROTÉINES ET DE NANOPARTICULES PEPTIDIQUES
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
182072215
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3466264
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
06/08/2010
Grant date:
27/01/2021
EP publication date:
10/04/2019
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
27/01/2021
EP B1 publication date:
27/01/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/08/2021
Expiration date (if granted and all annual fees paid):
06/08/2030
Applicant
1
Name:
Nanjing University
Legal Form:
From:
27/01/2021
Address:
22 Hankou Road
Nanjing, Jiangsu 210093, China (CN)
To:
2
Name:
Nanjing Effect Pharm Drug Development Corporation
Legal Form:
From:
27/01/2021
Address:
Room 108, Building 6,, 283 North Zhongshan Road
Nanjing
Jiangsu 210003, China (CN)
To:
Inventor
1
Name:
HU, Yiqiao
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
2
Name:
WU, Jinhui
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
3
Name:
DING, Dawei
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
4
Name:
GONG, Guangming
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
5
Name:
TANG, Xiaolei
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
6
Name:
TONG, Chunhui
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 210093, China (CN)
7
Name:
ZHU, Yan
Legal Form:
Address:
Gulou, Nanjing, Jiangsu 21009, China (CN)
8
Name:
LI, Shaoling
Legal Form:
Address:
Sunnyvale, CA California 94087, United States (US)